From Casetext: Smarter Legal Research

Seabrook v. Janssen Pharm.

United States District Court, S.D. New York
May 5, 2022
20 Civ. 2005 (ER) (S.D.N.Y. May. 5, 2022)

Opinion

20 Civ. 2005 (ER)

05-05-2022

JAMES SEABROOK, Plaintiff, v. JANSSEN PHARMACEUTICALS INC., JANSSEN RESEARCH & DEVELOPMENT LLC, NATASHA MYLES, MD JACQUES HACQUEBORD, ALEX GORSKY, and MICHAEL BOLUS, Defendants.


ORDER

EDGARDO RAMOS, U.S.D.J.

On December 1, 2021, the defendants Janssen Pharmaceuticals Inc. and Alex Gorsky filed a motion to dismiss the pro se plaintiff James Seabrook's Amended Complaint. To date, Seabrook has not filed an opposition.

Seabrook is therefore directed to file an opposition by June 6, 2022. Failure to comply with Court orders may result in sanctions, including dismissal for failure to prosecute pursuant to Fed.R.Civ.P. 41(b).

The Clerk of Court is respectfully directed to mail a copy of this Order to Seabrook.

It is SO ORDERED.


Summaries of

Seabrook v. Janssen Pharm.

United States District Court, S.D. New York
May 5, 2022
20 Civ. 2005 (ER) (S.D.N.Y. May. 5, 2022)
Case details for

Seabrook v. Janssen Pharm.

Case Details

Full title:JAMES SEABROOK, Plaintiff, v. JANSSEN PHARMACEUTICALS INC., JANSSEN…

Court:United States District Court, S.D. New York

Date published: May 5, 2022

Citations

20 Civ. 2005 (ER) (S.D.N.Y. May. 5, 2022)